Slide 1: Dexcom earnings Q1 2025
bpexcom Dexcom earnings OIE aoc Acag ' Q12025 Hi Bgiabetes
Slide 2: Safe harbor statement
Safe harbor statement This presentation contains “forward-looking statements” that are based on our management's beliefs and assumptions and on information available to management as of May 1, 2025. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward
Slide 3: First quarter 2025
First quarter 2025 idl © Key Financial Strategic $1.036 billion in revenue Highlights Highlights 14% organic revenue! growth over Q1'24 Generated ~280bps of operating Secured broader type 2 non-insulin (15% US; 12% INT'L?) expense leverage compared to coverage in the US Qt'24 Subsequent to the quart
Slide 4: First quarter performance
First quarter performance Total Revenue & Organic Growth Rate”! Non-GAAP Gross Profit and Margin* (sm™) ($MM) $1,114 Heo $921 $1,004 $994 $1,036 be $569 $638 $626 $661 $596 $800 $450 $600 $400 $300 $200 +16% +3% +8% +14% $150 63.5% 63.0% 59.4% 57.5% $0 $0 ar24 Q224 Q3'24 Qa24 ar2s ar24 Q224 Q324 Q42
Slide 5: 2025 Guidance as of May 1, 2025
2025 Guidance as of May 1, 2025 2025 Annual Revenue and Profitability Guidance Non-GAAP Non-GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin*! : usD 5 Previous 44.60 bilion ~64-65% ~21% ~30% USD Updated 4.60 billion ~62% ~21% ~30% 1 See appendix for the definition of Adjust
Slide 6: Appendix
bpexcom Appendix Revenue Data and GAAP Reconciliations
Slide 7: GAAP gross profit and net income reconciliation
Three Months Ended March 31, Three Months Ended March 31, (In millions) 2025 2024 (In millions, except per share data) 2025 2024 GAAP gross profit $ 589.0 $ 561.9 GAAP net income $ 105.4 $ 146.4 Amortization of intangible assets (1) 7.2 7.2 Amortization of intangible assets (1) 7.9 10.4 Non-GAAP gro
Slide 8: Revenue Metrics By Component
Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 543.2 $ 597.7 $ 666.6 $ 714.8 $ 651.9 $ 778.0 $ 873.8 $ 947.0 $ 854.3 $ 947.0 $ 951.8 $ 1,068.5 $ 997.2 Year over year growth 28% 21% 22% 19% 20% 30%
Slide 9: Revenue Metrics By Geography
Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Revenue Metrics By Geography US Revenue (millions) $ 451.2 $ 511.0 $ 573.4 $ 606.4 $ 526.0 $ 616.6 $ 713.6 $ 769.1 $ 653.2 $ 731.9 $ 701.9 $ 802.8 $ 750.5 Year over year growth 18% 11% 17% 17% 17% 21% 24% 27% 24% 19% (2%)
Slide 10: Organic revenue by geography
Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 (1) Organic Revenue INT'L Revenue - Reported $ 177.6 $ 185.2 $ 196.2 $ 208.8 $ 215.5 $ 254.7 $ 261.4 $ 265.4 $ 267.8 $ 272.4 $ 292.3 $ 310.7 $ 285.5 Impact of Acquired Revenue (6.4) (9.0) (3.0) 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Slide 11: DexCom, Inc.
DexCom, Inc. Amortization of intangible assets - We are required under GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful lives. We exclude these non-cash amortization charges related to acquired intangible assets from our n